KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Other financing activities (2024 - 2026)

Boston Scientific's Other financing activities history spans 3 years, with the latest figure at $3.0 million for Q1 2026.

  • On a quarterly basis, Other financing activities rose 130.0% to $3.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $20.0 million, a 400.0% increase, with the full-year FY2025 number at $7.0 million, up 800.0% from a year prior.
  • Other financing activities hit $3.0 million in Q1 2026 for Boston Scientific, down from $9.0 million in the prior quarter.
  • Over the last five years, Other financing activities for BSX hit a ceiling of $11.0 million in Q3 2024 and a floor of -$10.0 million in Q1 2025.
  • Historically, Other financing activities has averaged $3.4 million across 3 years, with a median of $3.0 million in 2024.
  • The widest YoY moves for Other financing activities: up 200.0% in 2025, down 109.09% in 2025.
  • Tracing BSX's Other financing activities over 3 years: stood at $3.0 million in 2024, then skyrocketed by 200.0% to $9.0 million in 2025, then crashed by 66.67% to $3.0 million in 2026.
  • Business Quant data shows Other financing activities for BSX at $3.0 million in Q1 2026, $9.0 million in Q4 2025, and -$1.0 million in Q3 2025.